ZA200501839B - Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor - Google Patents

Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor

Info

Publication number
ZA200501839B
ZA200501839B ZA200501839A ZA200501839A ZA200501839B ZA 200501839 B ZA200501839 B ZA 200501839B ZA 200501839 A ZA200501839 A ZA 200501839A ZA 200501839 A ZA200501839 A ZA 200501839A ZA 200501839 B ZA200501839 B ZA 200501839B
Authority
ZA
South Africa
Prior art keywords
achaete
scute
polypeptides
tumor
diagnosis
Prior art date
Application number
ZA200501839A
Other languages
English (en)
Inventor
Baldwin Daryl
Clark Hilary
Jubb Adrian
Koeppen Hartmut
Quan Clifford
Thomas D Wu
Zhang Zemin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200501839B publication Critical patent/ZA200501839B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200501839A 2002-08-29 2003-06-04 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor ZA200501839B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40708702P 2002-08-29 2002-08-29

Publications (1)

Publication Number Publication Date
ZA200501839B true ZA200501839B (en) 2006-10-25

Family

ID=31978417

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501839A ZA200501839B (en) 2002-08-29 2003-06-04 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor

Country Status (9)

Country Link
US (2) US20050260634A1 (xx)
EP (1) EP1575515A4 (xx)
JP (1) JP2006512901A (xx)
KR (1) KR20050057047A (xx)
AU (1) AU2003243398A1 (xx)
CA (1) CA2496925A1 (xx)
MX (1) MXPA05002287A (xx)
WO (1) WO2004019857A2 (xx)
ZA (1) ZA200501839B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090085697A (ko) 2000-02-23 2009-08-07 글락소스미스클라인 바이오로지칼즈 에스.에이. 종양 특이적 동물 단백질
US7811574B2 (en) 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
CA2496925A1 (en) * 2002-08-29 2004-03-11 Genentech, Inc. Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
NZ596501A (en) 2009-05-27 2013-11-29 Glaxosmithkline Biolog Sa Casb7439 constructs
US10260089B2 (en) 2012-10-29 2019-04-16 The Research Foundation Of The State University Of New York Compositions and methods for recognition of RNA using triple helical peptide nucleic acids
CN116756272B (zh) * 2023-06-20 2024-02-23 广州大学 面向中文威胁报告的att&ck模型映射方法及装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708871A (en) * 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US5571689A (en) * 1988-06-16 1996-11-05 Washington University Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5208020A (en) * 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
CA2090860C (en) * 1990-11-21 2003-09-16 Richard A. Houghten Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
DK0564531T3 (da) * 1990-12-03 1998-09-28 Genentech Inc Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
US5641870A (en) * 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US7442776B2 (en) * 1999-10-08 2008-10-28 Young David S F Cancerous disease modifying antibodies
KR20090085697A (ko) * 2000-02-23 2009-08-07 글락소스미스클라인 바이오로지칼즈 에스.에이. 종양 특이적 동물 단백질
CA2496925A1 (en) * 2002-08-29 2004-03-11 Genentech, Inc. Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor

Also Published As

Publication number Publication date
MXPA05002287A (es) 2005-08-18
WO2004019857A3 (en) 2006-03-16
CA2496925A1 (en) 2004-03-11
EP1575515A4 (en) 2007-08-08
JP2006512901A (ja) 2006-04-20
AU2003243398A1 (en) 2004-03-19
WO2004019857A2 (en) 2004-03-11
EP1575515A2 (en) 2005-09-21
KR20050057047A (ko) 2005-06-16
US20050260634A1 (en) 2005-11-24
US20070117124A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
EP1571968A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
IL165950A0 (en) Compositions and method for the diagnosis and treatment of tumor
EP1578996A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
EP1553912A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
IL174047A0 (en) Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
EP1575571A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR
EP1551990A4 (en) DIAGNOSIS AND TREATMENT OF CHEMOSTORED TUMORS
EP1576169A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME, AND METHODS OF USE THEREOF
AU2003294217A8 (en) Human polypeptides encoded by polynucleotides and methods of their use
IL162201A0 (en) New methods for diagnosis and treatment of tumours
EP1581652A4 (en) IDENTIFICATION OF SEQUENCES PARTICULAR USEFUL IN THE DIAGNOSIS AND IDENTIFICATION OF THERAPEUTIC TARGETS FOR OSTEO ARTHRITIS
HK1079220A1 (en) Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases cd83
ZA200510282B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1487864A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES AND METHODS OF USE THEREOF
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200501839B (en) Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1695078A4 (en) METADHERINE POLYPEPTIDES, CODING NUCLEIC ACIDS AND METHOD OF USE
EP1401858A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS COATING THEREOF AND METHOD OF USE
EP1432726A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS CODED FOR THEM, AND METHOD OF USE
EP1549671A4 (en) THERAPEUTIC POLYPEPTIDES, THESE CODING NUCLEIC CAUSE, AND USE PROCESS
EP1539985A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES, AND METHODS OF USE
EP1399537A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF USE
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
ZA200604365B (en) Compositions and methods for the diagnosis and treatment of tumor